The tumour microenvironment, particularly immune cell infiltration, has been increasingly recognised as a key contributor to a tumour's initiation, progression, metastasis and response to therapy (PD‐L1; Programmed cell death‐ligand 1). The gene discussed is CD274; the disease is neoplasm.